On Sept. 19th, 2007, the Canadian Patent Office (CIPO) granted an authorisation to the Canadian generic manufacturer Apotex Inc. for the production of a certain volume of APO-TRIOVIR for export into Rwanda.
Previous month, eyeforpharma and DigiRedo spent the afternoon with Fonny Schenck, the 20-year veteran from Johnson & Johnson, just recently departed after 7 years pioneering award-winning programmes in CRM and eBusiness integration, multi-channel optimisation and SFE support.
Finalising a review of the liver safety of systemic formulations of medicines containing nimesulide, the European Medicines Agency (EMEA) has concluded that the benefits of these medicines outweigh their risks, but that there is a need to limit the duration of use and to restrict …
New data show that the addition of Herceptin (trastuzumab) to chemotherapy prior to breast cancer surgery (neoadjuvant therapy) completely eradicates tumours in nearly three times as many women with inflammatory HER2-positive breast cancer compared to chemotherapy alone.
Latest Comments